Natixis Advisors
ACH

Natixis Advisors’s Accendra Health ACH Stock Holding History

Natixis Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,760
Closed -$409K – 1617
2024
Q1 		$409K Buy
+14,760
New +$328K ﹤0.01% 1432
2023
Q3 		– Sell
-12,010
Closed -$229K – 1516
2023
Q2 		$229K Buy
+12,010
New +$214K ﹤0.01% 1456
2022
Q2 		– Sell
-14,557
Closed -$641K – 1493
2022
Q1 		$641K Buy
14,557
+2,612
+22% +$112K ﹤0.01% 1231
2021
Q4 		$520K Buy
+11,945
New +$468K ﹤0.01% 1239

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's ACH Position: Q2 2024 in Review

Natixis Advisors sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 14,760 shares — an estimated $409K sold.

Natixis Advisors first reported a position in ACH in Q4 2021 and held it in 4 quarters. The position peaked at $641K in Q1 2022. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Natixis Advisors reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Natixis Advisors sold 14,760 Accendra Health shares in Q2 2024, an estimated $409K.
  • Natixis Advisors first reported a position in Accendra Health in Q4 2021 and held it in 4 quarters.
  • Natixis Advisors's Accendra Health position peaked at $641K in Q1 2022.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Natixis Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.